389
Views
5
CrossRef citations to date
0
Altmetric
Review

Dyspnea in Parkinson’s disease: an approach to diagnosis and management

, , , &
Pages 619-626 | Received 15 Mar 2020, Accepted 29 Apr 2020, Published online: 18 May 2020

References

  • Postuma RB, Berg D. Prodromal Parkinson’s disease: the decade past, the decade to come. Mov Disord. 2019;34(5):665–675.
  • Gan-Or Z, Alcalay RN, Rouleau GA, et al. Sleep disorders and Parkinson disease; lessons from genetics. Sleep Med Rev. 2018;41:101–112.
  • Pfeiffer RF. Non-motor symptoms in Parkinson’s disease. Parkinsonism Relat Disord. 2016;22(Suppl 1):S119–22.
  • Adler CH, Beach TG. Neuropathological basis of nonmotor manifestations of Parkinson’s disease. Mov Disord. 2016;31(8):1114–1119.
  • Chaudhuri KR, Martinez-Martin P, Brown RG, et al. The metric properties of a novel non-motor symptoms scale for Parkinson’s disease: results from an international pilot study. Mov Disord. 2007;22(13):1901–1911.
  • Antonini A, Barone P, Marconi R, et al. The progression of non-motor symptoms in Parkinson’s disease and their contribution to motor disability and quality of life. J Neurol. 2012;259(12):2621–2631.
  • Chaudhuri KR, Martinez-Martin P, Schapira AH, et al. International multicenter pilot study of the first comprehensive self-completed nonmotor symptoms questionnaire for Parkinson’s disease: the NMSQuest study. Mov Disord. 2006;21(7):916–923.
  • American Thoracic Society. Dyspnea mechanisms, assessment, and management: a consensus statement. Am J Respir Crit Care Med. 1999;159:321–340.
  • Weiner P, Inzelberg R, Davidovich A, et al. Respiratory muscle performance and the PERCEPTION of dyspnea in Parkinson’s disease. Can J Neurol Sci. 2002 Feb;29(1):68–72.
  • Buchanan GF, Richerson GB. Role of chemoreceptors in mediating dyspnea. Respir Physiol Neurobiol. 2009;167(1):9–19.
  • Kirkman E. Respiration: control of ventilation. Anaesth Intensive Care Med. 2011;12(10):446–449.
  • Benarroch EE. Brainstem respiratory control: substrates of respiratory failure of multiple system atrophy. Mov Disord. 2007;22(2):155–161.
  • Chowdhuri S, Badr S. Control of Ventilation in Health and Disease. Chest. 2017;151(4):917–929.
  • Bass JB. Chapter 36 Dyspnea. In: Walker HK, Hall WD, Hurst JW, editors. Clinical methods: the history, physical, and laboratory examinations. 3rd ed. 1990. p. 200–203.
  • Burki NK, Lee LY. Mechanisms of dyspnea. Chest. 2010;138(5):1196–1201.
  • Lansing RW, Gracely RH, Banzett RB. The multiple dimensions of dyspnea: review and hypotheses. Respir Physiol Neurobiol. 2009;167(1):53–60.
  • Simon PM, Schwartzstein RM, Weiss JW, et al. Distinguishable types of dyspnea in patients with shortness of breath. Am Rev Respir Dis. 1990;42:1009–1014.
  • Antoniu SA. Descriptors of dyspnea in obstructive lung diseases. Multidiscip Respir Med. 2010;5:216–219.
  • Caroci A, Lareau SC, Loma L. Descriptors of dyspnea by patients with chronic obstructive pulmonary disease versus congestive heart failure. Heart Lung. 2004;33(2):102–110.
  • Chowienczyk S, Javadzadeh S, Booth S, et al. Association of descriptors of breathlessness with diagnosis and self-reported severity of breathlessness in patients with advanced chronic obstructive pulmonary disease or cancer. J Pain Symptom Manage. 2016;52(2):259–264.
  • Baille G, Perez T, Devos D, et al. Dyspnea is a specific symptom in Parkinson’s disease. J Parkinsons Dis. 2019;9(4):785–791.
  • Borg GA. Psychophysical bases of perceived exertion. Med Sci Sports Exerc. 1982;14:377–381.
  • Stenton C. The MRC breathlessness scale. Occup Med. 2008;58:226–227.
  • Moreau C, Devos D, Baille G, et al. Are upper-body axial symptoms a feature of early Parkinson’s disease? PLoS One. 2016;11(9):e0162904.
  • Bayulkem K, Lopez G. Nonmotor fluctuations in Parkinson’s disease: clinical spectrum and classification. J Neurol Sci. 2010;289:89–92.
  • Stacy M. Nonmotor symptoms in Parkinson’s disease. Int J Neurosci. 2011;121(Suppl 2):9–17.
  • Tseng MT, Lin CH. Pain in early-stage Parkinson’s disease: implications from clinical features to pathophysiology mechanisms. J Formos Med Assoc. 2017;116(8):571–581.
  • Gibbons CH, Freeman R. Orthostatic dyspnea: a neglected symptom of orthostatic hypotension. Clin Auton Res. 2005;15(1):40–44.
  • Lee MA, Prentice WM, Hildreth AJ, et al. Measuring symptom load in Idiopathic Parkinson’s disease. Parkinsonism Relat Disord. 2007;13(5):284–289.
  • Barone P, Antonini A, Colosimo C, et al. The PRIAMO study: a multicenter assessment of nonmotor symptoms and their impact on quality of life in Parkinson’s disease. Mov Disord. 2009;24(11):1641–1649.
  • Baille G, Chenivesse C, Perez T, et al. Dyspnea: an underestimated symptom in Parkinson’s disease. Parkinsonism Related Disord. 2016. DOI:10.1016/j.parkreldis.2018.09.001
  • Torsney KM, Forsyth D. Respiratory dysfunction in Parkinson’s disease. J R Coll Physicians Edinb. 2017;47(1):35–39.
  • Izquierdo-Alonso JL, Jiménez-Jiménez FJ, Cabrera-Valdivia F, et al. Airway dysfunction in patients with Parkinson’s disease. Lung. 1994;172(1):47–55.
  • Sathyaprabha TN, Kapavarapu PK, Pal K, et al. Pulmonary functions in Parkinson’s disease. Indian J Chest Dis Allied Sci. 2005;47:251–257.
  • Pal PK, Sathyaprabha TN, Tuhina P, et al. Pattern of subclinical pulmonary dysfunctions in Parkinson’s disease and the effect of levodopa. Mov Disord. 2007;22(3):420–424.
  • Shaheen HA, Mohammad AA, Abd Elzaher MA. Parkinson’s Disease and pulmonary dysfunction. Egypt J Neurol Psychiat Neurosurg. 2009;46(1):129–140.
  • O’Callaghan A, Walker R. A review of pulmonary function in Parkinson’s disease. J Parkinsonism Restless Legs Syndrome. 2018;8:13–23.
  • Herer B, Arnulf I, Housset B. Effects of Levodopa on pulmonary function in Parkinson’s disease. Chest. 2001;119:387–393.
  • Vincken WG, Gauthier SG, Dollfuss RE, et al. Involvement of upper airway muscles in extrapyramidal disorders; a cause of airflow limitation. N Engl J Med. 1984 Aug 16;311:438–442.
  • Hovestadt A, Boggard JM, Meerwaldt JD, et al. Pulmonary Function in Parkinson’s disease. J Neurol Neruosurg Psychiatry. 1989;52:329–333.
  • Sabaté M, González I, Ruperez F, et al. Obstructive and restrictive pulmonary dysfunctions in Parkinsons disease. J Neurol Sci. 1995;138:114–119.
  • Rice JE, Antic R, Thompson PD. Disordered respiration as a levodopa-induced dyskinesia in Parkinson’s disease. Mov Disord. 2002;17(3):524–527.
  • Wang CM, Shieh WY, Weng YH, et al. Non-invasive assessment determine the swallowing and respiration dysfunction in early Parkinson’s disease. Parkinsonism Relat Disord. 2017;42:22–27.
  • Haas BM, Trew M, Castle PC. Effects of respiratory muscle weakness on daily living function, quality of life, activity levels, and exercise capacity in mild to moderate parkinsonʼs disease. Am J Phys Med Rehabil. 2004;83(8):601–607.
  • Guedes LU, Rodrigues JM, Fernandes AA, et al. Respiratory changes in Parkinson’s disease may be unrelated to dopaminergic dysfunction. Arq Neuropsiquiatr. 2012;70(11):847–851.
  • Silverman EP, Sapienza CM, Saleem A, et al. Tutorial on maximum inspiratory and expiratory mouth pressures in individuals with idiopathic Parkinson disease (IPD) and the preliminary results of an expiratory muscle strength training program. NeuroRehabilitation. 2006;21:71–79.
  • da Silva-júnior FP, Do Prado GF, Barbosa ER, et al. Sleep disordered breathing in Parkinson’s disease: a critical appraisal. Sleep Med Rev. 2014;18(2):173–178.
  • Postuma RB. Prodromal Parkinson’s disease – using REM sleep behavior disorder as a window. Parkinsonism Relat Disord. 2014;20:S1–S4.
  • Valko PO, Hauser S, Sommerauer M, et al. Observations on sleep-disordered breathing in idiopathic Parkinson’s disease. PLoS ONE. 2015;9(6):e100828.
  • Maria B, Sophia S, Michalis M, et al. Sleep breathing disorders in patients with idiopathic Parkinson’s disease. Respir Med. 2003;97(10):1151–1157.
  • Braak H, Del Tredici K, Rüb U, et al. Staging of brain pathology related to sporadic Parkinson’s disease. Neurobiol Aging. 2003;24:197–211.
  • Dickson DW. Neuropathology of Parkinson disease. Parkinsonism Related Disord. 2018;46(s1):S30–S3.
  • Seccombe LM, Giddings HL, Rogers PG, et al. Abnormal ventilatory control in Parkinson’s disease-further evidence for non-motor dysfunction. Respir Physiol Neurobiol. 2011;179(2–3):300–304.
  • Zhang W, Zhang L, Zhou N, et al. Dysregulation of respiratory center drive (P0.1) and muscle strength in patients with early stage Idiopathic Parkinson’s disease. Front Neurol. 2019;10:724.
  • Vijayan S, Singh B, Ghosh S, et al. Brainstem ventilatory dysfunction: a plausible mechanism for dyspnea in Parkinson’s disease? Mov Disord. 2020 Jan 15;35:379–388.
  • Serebrovskaya T, Karaban I, Mankovskaya I, et al. Hypoxic ventilatory responses and gas exchange in patients with parkinson’s disease. Respiration. 1998;65:28–33.
  • Onodera H, Okabe S, Kikuchi Y, et al. Impaired chemosensitivity and perception of dyspnoea in Parkinson’s disease. Lancet. 2000;356(9231):739–740.
  • Baille G, De Jesus AM, Perez T, et al. Ventilatory dysfunction in Parkinson’s disease. J Parkinsons Dis. 2016;6(3):463–471.
  • De Pandis MF, Starace A, Stefanelli F, et al. Modification of respiratory function parameters in patients with severe Parkinson’s disease. Neurol Sci. 2002;23:69–70.
  • Tambasco N, Murgia N, Nigro P, et al. Levodopa-responsive breathing discomfort in Parkinson’s disease patients. J Neural Transm. 2018;125(7):1033–1036.
  • Vercueil L, Linard JP, Wuyam B, et al. Breathing pattern in patients with Parkinson’s disease. Respir Physiol. 1999;118:163–172.
  • Ko PW, Kang K, Lee HW. Levodopa-induced respiratory dysfunction confirmed by levodopa challenge test: a case report. Medicine (Baltimore). 2018;97(41):e12488.
  • Kurtis MM, Rajah T, Delgado LF, et al. The effect of deep brain stimulation on the non-motor symptoms of Parkinson’s disease: a critical review of the current evidence. NPJ Parkinsons Dis. 2017;2:16024.
  • Dafsari HS, Reddy P, Herchenbach C, et al. Beneficial effects of bilateral subthalamic STIMULATION on non-motor symptoms in parkinson’s disease. Brain Stimul. 2016;9(1):78–85.
  • Chalif JI, Sitsapesan HA, Pattinson KTS, et al. Dyspnea as a side effect of subthalamic nucleus deep brain stimulation for Parkinson’s disease. Respir Physiol Neurobiol. 2014;192:128–133.
  • Inzelberg R, Peleg N, Nisipeanu P, et al. Inspiratory muscle training and the perception of dyspnea in Parkinson’s disease. Can J Neurol Sci. 2005;32(2):213–217.
  • Canning CG, Alison JA, Allen NE, et al. Parkinson’s disease: an investigation of exercise capacity, respiratory function, and gait. Arch Phys Med Rehabil. 1997;78:199–207.
  • Ramazzina I, Bernazzoli B, Costantino C. Systematic review on strength training in Parkinson’s disease: an unsolved question. Clin Interv Aging. 2017;12:619–628.
  • Hirsch MA, Farley BG. Exercise and neuroplasticity in persons living with Parkinson’s disease. Eur J Phys Rehabil Med. 2009 June;45(2):215–229.
  • Güngen B, Aydemir Y, Aras Y, et al. The effects of a pulmonary rehabilitation program on exercise tolerance, quality of life, sleep quality and emotional status in the patients with Parkinson’s disease. Biomed Res (India). 2017;28(1):1–5.
  • Ellis T, Katz DI, White DK, et al. Effectiveness of an inpatient multidisciplinary rehabilitation program for people with Parkinson disease. Phys Ther. 2008;88:812–819.
  • Reyes A, Castillo A, Castillo J, et al. The effects of respiratory muscle training on peak cough flow in patients with Parkinson’s disease: a randomized controlled study. Clin Rehabil. 2018 Oct;32(10):1317–1327.
  • Reyes A, Castillo A, Castillo J, et al. The effects of respiratory muscle training on phonatory measures in individuals with Parkinson’s disease. J Voice. 2019. DOI:10.1016/j.jvoice.2019.05.001
  • Darling-White M, Huber JE. The impact of expiratory muscle strength training on speech breathing in individuals with Parkinson’s disease: a preliminary study. Am J Speech Lang Pathol. 2017;26(4):1159–1166.
  • Monteiro L, Souza-Machado A, Pinho P, et al. Swallowing impairment and pulmonary dysfunction in Parkinson’s disease: the silent threats. J Neurol Sci. 2014;339(1–2):149–152.
  • Benarroch EE, Schmeichel AM, Low PA, et al. Depletion of ventromedullary NK-1 receptor-immunoreactive neurons in multiple system atrophy. Brain. 2003;126:2183–2190.
  • Glass GA, Jospehs KA, Ahlskog E. Respiratory insufficiency as the primary presenting symptom of multiple-system atrophy. Arch Neurol. 2006;63(7):978–981.
  • Schwarzacher SW, Rüb U, Deller T. Neuroanatomical characteristics of the human pre-botzinger complex and its involvement in neurodegenerative brainstem diseases. Brain. 2011;134(Pt 1):24–35.
  • Presti MF, Schmeichel AM, Low PA, et al. Degeneration of brainstem respiratory neurons in dementia with Lewy bodies. Sleep. 2014;37(2):373–378.
  • Baille G, Perez T, Devos D, et al. Early occurrence of inspiratory muscle weakness in Parkinson’s disease. PLoS One. 2018;13(1):e0190400.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.